A humanized mouse model of hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia

Endocrinology (United States)

Volumn 155, Issue 11, 2014, Pages 4137-4148

  Lee, Seong Min ^a   Goellner, Joseph J ^b   O'Brien, Charles A ^b   Pike, J Wesley ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; LEUCINE; SERINE; 1,25-DIHYDROXYVITAMIN D; CALCITRIOL RECEPTOR; VDR PROTEIN, HUMAN; VITAMIN D;

ALOPECIA; ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CLINICAL FEATURE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HEREDITARY CALCITRIOL RESISTANT RICKETS; MOUSE; MOUSE STRAIN; MUTANT; NONHUMAN; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RICKETS; SKIN CYST; TARGET ORGAN; TRANSGENE; WESTERN BLOTTING; AMINO ACID SUBSTITUTION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; DRUG RESISTANCE; FAMILIAL HYPOPHOSPHATEMIC RICKETS; GENETICS; HUMAN; PATHOLOGY; TRANSGENIC MOUSE;

ALOPECIA; AMINO ACID SUBSTITUTION; ANIMALS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; FAMILIAL HYPOPHOSPHATEMIC RICKETS; HUMANS; LEUCINE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, CALCITRIOL; SERINE; VITAMIN D;

EID: 84908054269     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1417     Document Type: Article

References (63)

1. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726-776.
2. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6 suppl):1689S-1696S.
3. 3 receptors during the murine hair cycle. Br J Dermatol. 1994;131:477-482.
4. Sakai Y, Demay MB. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. Endocrinology. 2000;141:2043-2049.
5. 3 receptors in human leukocytes. Science. 1983;221:1181-1183.
6. 3 promotes IL-10 production in human B cells. Eur J Immunol. 2008;38:2210-2218.
7. Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol. 2014;5:151.
8. 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-238.
9. Chen S, Law CS, Grigsby CL, et al. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation. 2011;124:1838-1847.
10. Ordonez-Moran P, Larriba MJ, Pendas-Franco N, Aguilera O, Gonzalez-Sancho JM, Munoz A. Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci. 2005;10:2723-2749.
11. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835-839.
12. Pike JW, Meyer MB, Bishop KA. Regulation of target gene expression by the vitamin D receptor - an update on mechanisms. Rev Endocr Metab Disord. 2012;13:45-55.
13. Pike JW, Meyer MB. Fundamentals of vitamin D hormone-regulated gene expression [published online November 12, 2013]. J Steroid Biochem Mol Biol. doi:10.1016/j.jsbmb.2013.11.004.
14. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83:841-850.
15. Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev. 2004;25:45-71.
16. 3 24-hydroxylase. Mol Cell Biol. 2005;25:472-487.
17. Kong J, Zhu X, Shi Y, et al. VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system. Mol Endocrinol. 2013;27:2116-2125.
18. Salehi-Tabar R, Nguyen-Yamamoto L, Tavera-Mendoza LE, et al. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proc Natl Acad Sci USA. 2012;109:18827-18832.
19. Larriba MJ, González-Sancho JM, Bonilla F, Muñoz A. Interaction of vitamin D with membrane-based signaling pathways. Front Physiol. 2014;5:60.
20. Xie Z, Chang S, Oda Y, Bikle DD. Hairless suppresses vitamin D receptor transactivation in human keratinocytes. Endocrinology. 2006;147:314-323.
21. Meyer MB, Goetsch PD, Pike JW. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J Steroid Biochem Mol Biol. 2010;121:136-141.
22. Meyer MB, Goetsch PD, Pike JW. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol Endocrinol. 2012;26:37-51.
23. 3 elicits a genomewide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 2011;39:9181-9193.
24. Brooks MH, Bell NH, Love L, et al. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med. 1978;298:996-999.
25. Marx SJ, Spiegel AM, Brown EM, et al. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab. 1978;47:1303-1310.
26. Feldman D, Malloy PJ. Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets. Bonekey Rep. 2014;3:510.
27. Feldman D, Malloy PJ, Miller WL. Genetic disorders of vitamin D synthesis and action. In: Thakker RV, Whyte MP, Eisman J, Igarashi T, eds. Genetics of Bone Biology and Skeletal Disease. San Diego, CA: Elsevier; 2013:537-552.
28. 3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology. 2001;142:3135-3141.
29. Panda DK, Miao D, Tremblay ML, et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, andimmunedysfunction. Proc Natl Acad Sci USA. 2001;98:7498-7503.
30. Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin Dreceptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16:391-396.
31. Li YC, Pirro AE, Amling M, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA. 1997;94:9831-9835.
32. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci USA. 2001;98:13324-13329.
33. Erben RG, Soegiarto DW, Weber K, et al. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol. 2002;16:1524-1537.
34. Chen CH, Sakai Y, Demay MB. Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. Endocrinology. 2001;142:5386-5389.
35. Skorija K, Cox M, Sisk JM, et al. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol Endocrinol. 2005;19:855-862.
36. Kong J, Li XJ, Gavin D, Jiang Y, Li YC. Targeted expression of human vitamin D receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. J Invest Dermatol. 2002;118:631-638.
37. Miyamoto K, Kesterson RA, Yamamoto H, et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol. 1997;11:1165-1179.
38. Jehan F, DeLuca HF. Cloning and characterization of the mouse vitamin D receptor promoter. Proc Natl Acad Sci USA. 1997;94:10138-10143.
39. 3. Mol Endocrinol. 2006;20:1231-1247.
40. Zella LA, Meyer MB, Nerenz RD, Lee SM, Martowicz ML, Pike JW. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol. 2010;24:128-147.
41. Lee SM, Bishop KA, Goellner JJ, O'Brien CA, Pike JW. Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype. Endocrinology. 2014;155:2064-2076.
42. 3. J Biol Chem. 2010;285:15599-15610.
43. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, et al. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA. 1992;89:4658-4662.
44. Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol. 1994;8:910-918.
45. Arnold SF, Obourn JD, Jaffe H, Notides AC. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding. J Steroid Biochem Mol Biol. 1995;55:163-172.
46. Patrone C, Gianazza E, Santagati S, Agrati P, Maggi A. Divergent pathways regulate ligand-independent activation of ERα in SK-N-BE neuroblastoma and COS-1 renal carcinoma cells. Mol Endocrinol. 1998;12:835-841.
47. Wang Q, Li W, Zhang Y, et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell. 2009;138:245-256.
48. Malloy PJ, Feldman BJ. Cell-autonomous regulation of brown fat identity gene UCP1 by unliganded vitamin D receptor. Mol Endocrinol. 2013;27:1632-1642.
49. 3 in bone cells: exploiting new approaches and defining new mechanisms. Bonekey Rep. 2014;3:482.
50. Makishima M, Lu TT, Xie W, et al. Vitamin D receptor as an intestinal bile acid sensor. Science. 2002;296:1313-1316.
51. 3 potentiates the keratinocyte response to calcium. J Biol Chem. 1994;269:14723-14729.
52. 3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels. J Clin Invest. 1995;96:602-609.
53. Xie Z, Bikle DD. Cloning of the human phospholipase C-γ1 promoter and identification of a DR6-type vitamin D-responsive element. J Biol Chem. 1997;272:6573-6577.
54. Bikle DD, Chang S, Crumrine D, et al. 25 Hydroxyvitamin D 1α- hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol. 2004;122:984-992.
55. 3 receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis. 2002;23:2103-2109.
56. Teichert AE, Elalieh H, Elias PM, Welsh J, Bikle DD. Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice. J Invest Dermatol. 2011;131:2289-2297.
57. Ellison TI, Smith MK, Gilliam AC, MacDonald PN. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J Invest Dermatol. 2008;128:2508-2517.
58. 3 in human skin and the physiologic consequences. Science. 1980;210:203-205.
59. 3-1α-hydroxylase. J Clin Endocrinol Metab. 2001;86:888-894.
60. 3 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells. Mol Pharmacol. 2009;75:1392-1399.
61. 3 receptors. Differential quantitation of endogenously occupied and unoccupied sites. J Biol Chem. 1980;255:9534-9537.
62. Dokoh S, Haussler MR, Pike JW. Development of a radioligand immunoassay for 1,25-dihydroxycholecalciferol receptors utilizing monoclonal antibody. Biochem J. 1984;221:129-136.
63. Zarach JM, Beaudoin GM 3rd, Coulombe PA, Thompson CC. The co-repressor hairless has a role in epithelial cell differentiation in the skin. Development. 2004;131:4189-4200.